FinnCap reissued their corporate rating on shares of ANGLE (LON:AGL) in a research note issued to investors on Tuesday morning, ThisIsMoney.Co.Uk reports.

Shares of LON AGL opened at GBX 77 ($1.01) on Tuesday. The firm’s 50-day moving average price is GBX 72.70 and its 200-day moving average price is GBX 66.02. The stock has a market capitalization of $133.02 million and a price-to-earnings ratio of -11.67. ANGLE has a 12-month low of GBX 38 ($0.50) and a 12-month high of GBX 79.99 ($1.05).

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests rare circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application and others.

Further Reading: Rule of 72

Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.